Recherche
-
Spontaneous reporting of adverse-drug reactions as an outlet for patient dismay? The case of Levothyrox(R) change of excipients
(Fundamental and Clinical Pharmacology, 2022-01-06)Article de revue -
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
(European Journal of Clinical Pharmacology. vol. 78, pp. 1981-1990, 2022-10-26)Article de revue -
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
(Diabetes Care, 2022-11-10)Article de revue -
Trends in use of benzodiazepines and Z-drugs in France from 2012 to 2020
(Therapies, 2022-12-09)Article de revue -
Bidisciplinary dermatology-pharmacovigilance consultations: Results of a two-year study
(Annales de Dermatologie et de Vénéréologie, 2022-12-07)Article de revue -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès -
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use
(Frontiers in Psychiatry. vol. 13, 2022-06-30)Article de revueLibre accès -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueLibre accès -
Antiherpetic drugs: a potential way to prevent Alzheimer's disease?
(Alzheimer's Research and Therapy. vol. 14, n° 1, pp. 3, 2022-01-07)Article de revueLibre accès